Correlation Between Verona Pharma and Carmell Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verona Pharma and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verona Pharma and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verona Pharma PLC and Carmell Therapeutics, you can compare the effects of market volatilities on Verona Pharma and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verona Pharma with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verona Pharma and Carmell Therapeutics.

Diversification Opportunities for Verona Pharma and Carmell Therapeutics

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Verona and Carmell is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Verona Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verona Pharma PLC are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Verona Pharma i.e., Verona Pharma and Carmell Therapeutics go up and down completely randomly.

Pair Corralation between Verona Pharma and Carmell Therapeutics

Given the investment horizon of 90 days Verona Pharma PLC is expected to generate 0.45 times more return on investment than Carmell Therapeutics. However, Verona Pharma PLC is 2.22 times less risky than Carmell Therapeutics. It trades about 0.22 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.09 per unit of risk. If you would invest  3,419  in Verona Pharma PLC on August 31, 2024 and sell it today you would earn a total of  571.00  from holding Verona Pharma PLC or generate 16.7% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Verona Pharma PLC  vs.  Carmell Therapeutics

 Performance 
       Timeline  
Verona Pharma PLC 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Carmell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Carmell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Verona Pharma and Carmell Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verona Pharma and Carmell Therapeutics

The main advantage of trading using opposite Verona Pharma and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verona Pharma position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.
The idea behind Verona Pharma PLC and Carmell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamental Analysis
View fundamental data based on most recent published financial statements